NCT06597318 Trends of Patient-reported Outcome Measures (PROMs) in Multimorbid Medical Patients Hospitalized for an Acute Illness
| NCT ID | NCT06597318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Lausanne Hospitals |
| Condition | PROM |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-07-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-07-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
currently, PROMs and PREMs are not routinely collected and compared among medical inpatients of Swiss university hospitals, nor is a standard set of PROMs and PREMs available for use in Swiss hospitals. The project aims to examine trends in patient-reported outcomes (PROMs), including symptoms, quality of life, and distress, in multimorbid hospitalized patients from admission to 30 days post-discharge. It will also investigate whether PROMs at discharge are linked to the risk of readmission or emergency visits and explore how these outcomes differ in patients who receive low-value care. Additionally, the project will assess the relationship between patient-reported experiences (PREMs) and the provision of low-value care during the hospital stay.
Eligibility Criteria
Inclusion Criteria: * eligible for the LUCID registry (CER-VD AO\_2023-00029) \[Age ≥ 18 years, hospitalized in one of the five participating university hospitals (Geneva, Lausanne, Bern, Zürich, Basel), after 01.01.2014, and admitted to general internal medicine wards * Multimorbid patients (2 or more chronic diseases, defined as chronic conditions defined by international classification of diseases, 10th revision, codes with an estimated expected duration of at least 6 months or based on a clinical decision. * Acute illness * Signature of study specific informed consent Exclusion Criteria: * Not able to speak French, German or English * Foreseen length of stay of less than 4 days (estimated by study collaborators) * Prior inclusion in the TRADUCE study * Incapacity of discernment, i.e. cognitive impairment which could interfere with the ability to fill in PROMs tools
Contact & Investigator
Jerome Stirnemann, MD
PRINCIPAL INVESTIGATOR
University Hospital, Geneva
Frequently Asked Questions
Who can join the NCT06597318 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PROM. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06597318 currently recruiting?
Yes, NCT06597318 is actively recruiting participants. Contact the research team at marie.mean@chuv.ch for enrollment information.
Where is the NCT06597318 trial being conducted?
This trial is being conducted at Lausanne, Switzerland.
Who is sponsoring the NCT06597318 clinical trial?
NCT06597318 is sponsored by University of Lausanne Hospitals. The principal investigator is Jerome Stirnemann, MD at University Hospital, Geneva. The trial plans to enroll 1,000 participants.